Who owns ACUMEN PHARMACEUTICALS INC?
- Ticker: ABOS
- CUSIP Number: 00509g209
Tip: Access positions for across all investors
Analyze quarterly positions in Acumen Pharmaceuticals with up to 7 years of data, all consolidated into one spreadsheet
Download as csv
Download as Excel
Top investors of Acumen Pharmaceuticals stock
Who bought or sold ACUMEN PHARMACEUTICALS INC this quarter?
| Fund or Company Name | Shares Held | Valued At | Change in Shares | As Of | Actions |
|---|---|---|---|---|---|
| RA Capital Management | 15M | $37M | 0% | Sep 2024 |
|
| Franklin Resources | 3.5M | $8.3M | 5% | Sep 2024 |
|
| Sands Capital Ventures | 3.4M | $8.5M | 0% | Sep 2024 |
|
| BlackRock | 2.3M | $5.8M | 100% | Sep 2024 |
|
| Rock Springs Capital Management | 2.3M | $5.6M | 0% | Jun 2024 |
|
| BlackRock | 2.2M | $5.2M | 1038% | Jun 2024 |
|
| Vanguard Group | 1.9M | $4.6M | 14% | Jun 2024 |
|
| Jane Street | 1.2M | $2.9M | 173% | Sep 2024 |
|
| Alyeska Investment Group | 940k | $2.3M | 0% | Sep 2024 |
|
| Laurion Capital Management | 867k | $2.2M | -26% | Sep 2024 |
|
| Geode Capital Management | 865k | $2.1M | 6% | Sep 2024 |
|
| T. Rowe Price Associates | 850k | $2.1M | -19% | Sep 2024 |
|
| Hudson Bay Capital Management | 636k | $1.6M | -5% | Sep 2024 |
|
| Pathstone Holdings | 517k | $1.3M | 8% | Sep 2024 |
|
| State Street Corporation | 437k | $1.1M | 434% | Jun 2024 |
|
| Two Sigma Advisers | 392k | $949k | 81% | Jun 2024 |
|
| Two Sigma Investments | 311k | $752k | 75% | Jun 2024 |
|
| Northern Trust | 309k | $766k | 444% | Sep 2024 |
|
| Renaissance Technologies | 306k | $759k | -9% | Sep 2024 |
|
| Ikarian Capital | 266k | $661k | 0% | Sep 2024 |
|
| Bridgeway Capital Management | 148k | $359k | 0% | Jun 2024 |
|
| TD Asset Management | 139k | $345k | -6% | Sep 2024 |
|
| Bank of America Corporation | 139k | $344k | 13% | Sep 2024 |
|
| Susquehanna International | 130k | $322k | -47% | Sep 2024 |
|
| Group One Trading | 123k | $304k | -2% | Sep 2024 |
|
| Charles Schwab Investment Management | 109k | $270k | 0% | Sep 2024 |
|
| Bank of New York Mellon | 93k | $231k | -26% | Sep 2024 |
|
| Catalyst Financial Partners | 90k | $223k | 0% | Sep 2024 |
|
| Rhumbline Advisers | 89k | $219k | 69% | Sep 2024 |
|
| Morgan Stanley | 88k | $213k | 80% | Jun 2024 |
|
| Qube Research & Technologies | 76k | $184k | -55% | Jun 2024 |
|
| Citadel Advisors | 69k | $172k | -42% | Sep 2024 |
|
| Jpmorgan Chase & Co | 63k | $156k | 253% | Sep 2024 |
|
| Susquehanna Fundamental Investments | 63k | $151k | 0% | Jun 2024 |
|
| Barclays | 62k | $154k | 189% | Sep 2024 |
|
| Manufacturers Life Insurance Company | 60k | $145k | 0% | Jun 2024 |
|
| Nuveen Asset Management | 57k | $137k | 100% | Jun 2024 |
|
| Dimensional Fund Advisors | 57k | $140k | 0% | Sep 2024 |
|
| Murchinson | 56k | $136k | 100% | Jun 2024 |
|
| American Century Companies | 55k | $135k | 20% | Sep 2024 |
|
| Goldman Sachs Group | 51k | $124k | -84% | Jun 2024 |
|
| Citigroup | 31k | $76k | 225% | Sep 2024 |
|
| Intrepid Financial Planning Group | 30k | $75k | 0% | Sep 2024 |
|
| Tower Research Capital | 27k | $64k | 1779% | Jun 2024 |
|
| Mirae Asset Global Etfs Holdings | 23k | $57k | 100% | Sep 2024 |
|
| Virtu Financial | 22k | $55k | -9% | Sep 2024 |
|
| Susquehanna Portfolio Strategies | 22k | $53k | 0% | Jun 2024 |
|
| Sei Investments | 22k | $54k | 100% | Sep 2024 |
|
| Wells Fargo & Company | 21k | $53k | 4% | Sep 2024 |
|
| Jump Financial | 21k | $53k | -57% | Sep 2024 |
|
| Acadian Asset Management | 19k | $46k | 100% | Sep 2024 |
|
| Invesco | 18k | $45k | -4% | Sep 2024 |
|
| Pinnacle Wealth Management Advisory | 18k | $45k | 0% | Sep 2024 |
|
| SG Americas Securities | 18k | $44k | 100% | Sep 2024 |
|
| Deutsche Bank Aktiengesellschaft | 17k | $42k | -49% | Sep 2024 |
|
| Oxford Asset Management | 15k | $37k | 100% | Jun 2024 |
|
| Stifel Financial | 14k | $33k | -7% | Jun 2024 |
|
| Fortitude Advisory Group | 13k | $33k | 100% | Sep 2024 |
|
| Advisor Group Holdings | 10k | $26k | 0% | Sep 2024 |
|
| New York State Common Retirement Fund | 9.8k | $24k | -77% | Sep 2024 |
|
| Royal Bank of Canada | 5.9k | $15k | 47% | Sep 2024 |
|
| Summit Investment Advisors | 4.1k | $10k | 0% | Sep 2024 |
|
| California State Teachers Retirement System | 3.0k | $7.5k | 0% | Sep 2024 |
|
| Federation des caisses Desjardins du Quebec | 1.5k | $3.7k | 100% | Sep 2024 |
|
| Amalgamated Bank | 1.5k | $4.0k | 0% | Sep 2024 |
|
| CWM | 168.00 | $0 | 100% | Sep 2024 |
|
| Sterling Capital Management | 133.00 | $329.999600 | 100% | Sep 2024 |
|
| NISA Investment Advisors | 100.00 | $248.000000 | 100% | Sep 2024 |
|
| Capital Performance Advisors | 52.00 | $129.001600 | 100% | Sep 2024 |
|
| Planning Capital Management Corp | 5.00 | $13.000000 | 0% | Sep 2024 |
|
Who sold out of Acumen Pharmaceuticals?
| Fund or Company Name | Date Sold | Shares Held | Valued At |
|---|---|---|---|
| Millennium Management | Jun 2024 | 2.0M | $4.7M |
| Parkman Healthcare Partners | Mar 2024 | 577k | $2.3M |
| Squarepoint Ops | Mar 2024 | 113k | $459k |
| Man Group | Jun 2024 | 106k | $256k |
| Caption Management | Jun 2024 | 75k | $182k |
| Schonfeld Strategic Advisors | Jun 2024 | 74k | $178k |
| Balyasny Asset Management | Mar 2024 | 64k | $259k |
| D. E. Shaw & Co | Jun 2024 | 55k | $133k |
| Marathon Trading Investment Management | Jun 2024 | 26k | $64k |
| ExodusPoint Capital Management | Mar 2024 | 26k | $104k |
| OMERS Administration Corporation | Mar 2024 | 24k | $96k |
| Leucadia National Corporation | Mar 2024 | 19k | $77k |
| Gail Mannix | Jun 2024 | 18k | $44k |
| Engineers Gate Manager | Jun 2024 | 12k | $28k |
| Gladius Capital Management | Jun 2024 | 11k | $27k |
| Cubist Systematic Strategies | Jun 2024 | 8.9k | $22k |
| Point72 | Jun 2024 | 4.0k | $9.7k |
| Sandy Spring Bank | Jun 2024 | 1.5k | $3.6k |
| Macquarie Group | Mar 2024 | 1.2k | $4.988000 |
| Kelly Financial Services | Jun 2024 | 944.00 | $2.3k |
| Redwood Wealth Management Group | Jun 2024 | 800.00 | $1.9k |